Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT05152459 · WITHDRAWN
Trial details
- NCT number
- NCT05152459
- Sponsor
- City of Hope Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.